Clinical value of NGAL, L-FABP and albuminuria in predicting GFR decline in type 2 diabetes mellitus patients.

PLoS One

Division of Endocrinology and Metabolism, Department of Internal Medicine, Chang Gung Memorial Hospital, Keelung, Taiwan.

Published: July 2013

Objectives: Neutrophil gelatinase-associated lipocalin (NGAL) and liver-type fatty acid binding protein (L-FABP) are emerging as excellent biomarkers in the urine and plasma for the early prediction of acute and chronic kidney injury. The aims of this prospective study were to determine the role of albuminuria, and that of serum and urine levels of NGAL and L-FABP as predictors of a decline in the glomerular filtration rate (GFR) in patients with type 2 diabetes.

Methods: A longitudinal cohort study with one hundred forty type 2 diabetic patients was conducted. Serum and urine levels of NGAL and L-FABP, and the urine albumin excretion rate were determined. The correlation between the kidney injury biomarkers and rate of GFR decline was analyzed.

Results: The eGFR of study subjects decreased significantly as the study progressed (86.4±31.1 vs. 74.4±27.3 ml/min/1.73 m(2), P<0.001), and the urine albumin excretion rate increased significantly (264.9±1060.3 vs. 557.7±2092.5 mg/day, P = 0.009). The baseline urine albumin excretion rate and serum L-FABP level were significantly correlated with baseline eGFR (P<0.05). The results of regression analysis for the correlations between the rate of eGFR change and the baseline levels of NGAL and L-FABP, and the urine albumin excretion rate showed that only the urine albumin excretion rate was significantly correlated with the rate of eGFR change (standardized coefficients: -0.378; t: -4.298; P<0.001).

Conclusions: Tubular markers, such as NGAL and L-FABP, may not be predictive factors associated with GFR decline in type 2 diabetic patients.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551928PMC
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0054863PLOS

Publication Analysis

Top Keywords

ngal l-fabp
12
gfr decline
8
kidney injury
8
serum urine
8
urine levels
8
levels ngal
8
rate gfr
8
clinical ngal
4
l-fabp
4
l-fabp albuminuria
4

Similar Publications

Article Synopsis
  • The study investigates the effects of isovaleramide (ISO), an alcohol dehydrogenase (ADH) inhibitor, on acute kidney injury caused by ethylene glycol (EG) poisoning in rats.* -
  • ISO was shown to significantly reduce liver ADH activity, inhibit the metabolism of EG, lower concentrations of toxic metabolites, and decrease kidney injury markers.* -
  • The findings suggest that ISO not only improves kidney health by reducing cell damage and calcium oxalate crystals but also lowers mortality rates, indicating its potential as a treatment for EG poisoning-related kidney injuries.*
View Article and Find Full Text PDF

Background: Renal dysfunction is a common complication following liver transplantation (LT). This study aimed to determine whether a comprehensive assessment of kidney function using nineteen serum and urinary biomarkers (BMs) within the first 48 h post-LT could enhance the prediction of severe acute kidney injury (AKI) and the need of kidney replacement therapy (KRT) during the first postoperative week.

Methods: Blood and urine (U) samples were collected during the pre- and postoperative periods.

View Article and Find Full Text PDF

Acute Kidney Injury in Children: A Focus for the General Pediatrician.

Children (Basel)

August 2024

Department of Woman, Child and of General and Specialized Surgery, Università degli Studi della Campania "Luigi Vanvitelli", Via Luigi de Crecchio 2, 80138 Naples, Italy.

Article Synopsis
  • Acute kidney injury (AKI) in children is often overlooked and poses significant challenges in pediatric healthcare, with various causes including renal damage and inflammation.
  • Diagnosis typically uses traditional markers like serum creatinine, as well as new biomarkers such as Cystatin C and NGAL, which help identify AKI more effectively.
  • Treatment focuses on supportive care and fluid management, with severe cases potentially requiring renal replacement therapy; raising awareness and incorporating new diagnostic tools could enhance outcomes for affected children.
View Article and Find Full Text PDF
Article Synopsis
  • Scientists created a tool called U-AKIpredTM to help doctors predict if critically ill patients will get acute kidney injury (AKI) within 12 hours, using urine tests.
  • They studied 680 patients, and found that 12 specific markers in urine, especially three main ones, were great for this prediction.
  • The tool showed really good results, helping doctors make decisions to prevent or treat AKI more effectively, and it can be accessed online for easy use.
View Article and Find Full Text PDF

Introduction: Acute kidney injury (AKI) defined by a substantial decrease in kidney function within hours to days and is often irreversible with higher risk to chronic kidney disease (CKD) transition.

Areas Covered: The authors discuss the diagnostic and predictive utilities of serum and urinary biomarkers on AKI and on the risk of AKI-to-CKD progression. The authors focus on the relevant literature covering evidence of circulating and urinary biomarkers' capability to predict the transition of AKI to CKD.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!